Update shared on 04 Nov 2025
Fair value Increased 3.72%Analysts have raised the fair value estimate for China Life Insurance from $25.01 to $25.94 per share. This reflects slightly improved valuation expectations, even though projections for growth and profitability remain more restrained.
What's in the News
- China Life Insurance issued new earnings guidance for the first three quarters of 2025, projecting net profit attributable to equity holders to increase by approximately 50% to 70% year-over-year, reaching between RMB156,785 million and RMB177,689 million. (Corporate Guidance)
- The Board of Directors scheduled a meeting on October 30, 2025 to consider and approve the company's unaudited results for the nine months ended September 30, 2025. (Board Meeting)
- Shareholders approved the distribution of an interim dividend of RMB 0.238 per share (equivalent to HKD 0.26024 per share) for the first half of 2025, with payment to H Share investors expected on November 21, 2025. (Dividend Increases)
- The Annual General Meeting held on September 25, 2025 approved amendments to the Articles of Association, including changes in bylaws and procedural rules for meetings. (Changes in Company Bylaws/Rules)
Valuation Changes
- The Fair Value Estimate has risen slightly from $25.01 to $25.94 per share.
- The Discount Rate remains virtually unchanged at 6.89%.
- The Revenue Growth outlook has fallen significantly, decreasing from 33.5% to 27.9%.
- The Net Profit Margin is lower, moving from 9.7% to 7.6%.
- The Future P/E ratio has increased, rising from 10.9x to 13.9x.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.